Phase I clinical trial of VSN16R, announced

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Phase I clinical trial of VSN16R, announced

Postby MSUK » Mon Nov 04, 2013 2:53 am

Phase I clinical trial of VSN16R, a potential treatment for spasticity in MS, announced

Canbex Therapeutics Ltd announced today that it has commenced a Phase I clinical trial to assess the safety and tolerability in humans of VSN16R, its novel, orally active lead compound aimed at treating spasticity in people with multiple sclerosis.

The first-in-man study of VSN16R will enrol a total of 72 healthy volunteers in a placebo-controlled, single ascending dose and multiple ascending dose design. The study is being carried out by Quintiles, the world’s leading clinical research organisation...... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2212
Joined: Wed Oct 14, 2009 2:00 pm

Advertisement

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service